This Article Full Text Full Text (PDF) All Versions of this Article: 92/2/462    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hampe, C. S. Articles by Balasubramanyam, A. Search for Related Content PubMed PubMed Citation Articles by Hampe, C. S. Articles by Balasubramanyam, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Diabetes Type 1 Related Collections Autoimmunity Diabetes and Insulin Pediatric Endocrinology

Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with ß-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus

Robert H. Williams Laboratory (C.S.H., T.R.H.), Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195; Translational Metabolism Unit (R.N., M.R.M., D.I., A.B.), Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, and Endocrine Service (R.N., G.G., A.B.), Ben Taub General Hospital, Houston, Texas 77030; and Bristol-Myers-Squibb, Co. (M.R.M.), Princeton, New Jersey 08540

Address all correspondence and requests for reprints to: Christiane S. Hampe, Ph.D., Department of Medicine, University of Washington, Seattle, Washington 98195. E-mail: champe{at}u.washington.edu.

Context: We previously characterized patients presenting with diabetic ketoacidosis prospectively into four subgroups of ketosis-prone diabetes mellitus (KPDM), based on the presence or absence of ß-cell autoimmunity (A+ or A–) and ß-cell functional reserve (B+ or B–). The A+B– KPDM subgroup comprises patients with classic, autoimmune type 1 diabetes, whereas the A+B+ KPDM subgroup has only partial ß-cell loss and a distinct clinical phenotype.

Objective: We hypothesized that epitope specificity of autoantibodies directed against the 65-kDa isoform of glutamate decarboxylase (GAD65) reflects differences in ß-cell destruction.

Design: Sera of sequential GAD65Ab-positive KPDM patients admitted for diabetic ketoacidosis (n = 36) were analyzed for their epitope recognition using five GAD65-specific recombinant Fab and their ability to inhibit GAD65 enzymatic activity. All patients were followed longitudinally to assess ß-cell functional reserve and insulin dependence.

Results: Binding to an amino-terminal epitope defined by monoclonal antibody DPD correlated positively with fasting serum C-peptide levels at baseline (P = 0.0008) and after 1 yr (P = 0.007). Binding to the DPD-defined epitope also correlated positively with area under the curve for C-peptide after glucagon stimulation (P = 0.007) and with homeostasis model assessment percent B at 1 yr (P = 0.03). Binding to the DPD-defined epitope was significantly stronger in A+B+ than in A+B– patients (P = 0.001). Sera of 16 patients (44%) significantly inhibited GAD65 enzymatic activity, but this did not correlate with ß-cell function.

Conclusion: DPD-defined epitope specificity is correlated directly with preserved ß-cell functional reserve in GAD65Ab-positive patients and is associated with the milder clinical phenotype of A+B+ KPDM.

This article has been cited by other articles:

				A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado Syndromes of Ketosis-Prone Diabetes Mellitus Endocr. Rev., May 1, 2008; 29(3): 292 - 302. [Abstract] [Full Text] [PDF]

				G. Fenalti, C. S. Hampe, Y. Arafat, R. H.P. Law, J. P. Banga, I. R. Mackay, J. C. Whisstock, A. M. Buckle, and M. J. Rowley COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of Autoreactivity Diabetes, May 1, 2008; 57(5): 1293 - 1301. [Abstract] [Full Text] [PDF]